Positron (OTCMKTS:POSC) vs. Guided Therapeutics (OTCMKTS:GTHP) Head-To-Head Contrast

Positron (OTCMKTS:POSC) and Guided Therapeutics (OTCMKTS:GTHP) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

Profitability

This table compares Positron and Guided Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Positron	-222.99%	N/A	-65.25%
Guided Therapeutics	N/A	N/A	-158.84%

Risk and Volatility

Positron has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500. Comparatively, Guided Therapeutics has a beta of 0.34, meaning that its share price is 66% less volatile than the S&P 500.

Insider & Institutional Ownership

9.7% of Guided Therapeutics shares are held by institutional investors. 17.2% of Positron shares are held by insiders. Comparatively, 66.8% of Guided Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings for Positron and Guided Therapeutics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Positron	0	0	0	0	N/A
Guided Therapeutics	0	0	0	0	N/A

Earnings & Valuation

This table compares Positron and Guided Therapeutics’ gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Positron	$740,000.00	43.80	-$1.64 million	N/A	N/A
Guided Therapeutics	$100,000.00	50.67	-$3.49 million	N/A	N/A

Positron has higher revenue and earnings than Guided Therapeutics.

About Positron

Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.

About Guided Therapeutics

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.